Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ESPR Esperion Therapeutics

Watchlist
5.900
-0.020-0.34%
Close  02/03 16:00 ET
6.040
+0.140+2.37%
Post Mkt Price 02/03 18:53 ET
High
6.269
Open
6.140
Turnover
12.86M
Low
5.840
Pre Close
5.920
Volume
2.17M
Market Cap
434.73M
P/E(TTM)
Loss
52wk High
8.870
Shares
73.68M
P/E(Static)
Loss
52wk Low
3.280
Float Cap
397.75M
Bid/Ask %
-75.00%
Historical High
120.960
Shs Float
67.42M
Volume Ratio
1.28
Historical Low
3.280
Dividend TTM
--
Div Yield TTM
--
P/B
-1.48
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.22%
Amplitude
7.25%
Avg Price
5.922
Lot Size
1
Float Cap
397.75M
Bid/Ask %
-75.00%
Historical High
120.960
Shs Float
67.42M
Volume Ratio
1.28
Historical Low
3.280
Dividend TTM
--
P/B
-1.48
Dividend LFY
--
Turnover Ratio
3.22%
Amplitude
7.25%
Avg Price
5.922
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
CEO: Mr. Sheldon L. Koenig
Market: NASDAQ
Listing Date: 06/26/2013
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist